Zimmer Biomet Holdings Inc ZBH shares trading lower by $16.50 at $106.55 in Monday's session. After an inline Q3 report, the issue is being punished for its lowered FY 2016 EPS and sales guidance.
The issue, which made its all-time high ($131.25) and closing high ($131) on October 7, is now much closer to the $100 level.
After falling sharply in pre-market trading, it did manage a $1+ bounce off the open to $108 before resuming is downward course.
So far, its has reached $103.93 and has staged a rebound to the $106 area. That low corresponds with a series of seven lows it made in the $103 handle from March 18 to March 29.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.